(University of Pennsylvania School of Medicine) A new study, published this month in Lancet HIV by Penn Medicine researchers, shows that a naltrexone implant placed under the skin was more effective at helping HIV-positive patients with an opioid addiction reduce relapse and have better HIV-related outcomes compared to the oral drug.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2Cv0rwv
No comments:
Post a Comment